BNR
HEALTHCAREBurning Rock Biotech Ltd
$17.01-0.01 (-0.09%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving BNR Today?
No stock-specific AI insight has been generated for BNR yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.26$41.72
$17.01
Fundamentals
Market Cap$179M
P/E Ratio—
EPS$-0.76
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin-0.1%
Debt / Equity—
Trading
Volume4K
Avg Volume (10D)—
Shares Outstanding8.8M
BNR News
13 articles- Burning Rock Publishes 2025 Annual Report on Form 20-FYahoo Finance·Apr 28, 2026
- Burning Rock Announces Founder’s Purchase of Its ADSsYahoo Finance·Apr 2, 2026
- Brenntag Q4 Earnings Call HighlightsMarketbeat·Mar 12, 2026
- Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 12, 2026
- Burning Rock Announces Results of 2025 Annual General MeetingYahoo Finance·Dec 23, 2025
- Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025Yahoo Finance·Dec 1, 2025
- This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New HighsBarchart·Nov 26, 2025
- Burning Rock Reports Third Quarter 2025 Financial ResultsYahoo Finance·Nov 20, 2025
- Liquid Biopsy for Early Cancer Detection and Monitoring Market Report 2025-2033, with Profiles of GRAIL, AnchorDx, Burning Rock Biotech, Genecast, Guardant Health, Elypta, Freenome, and OncimmuneYahoo Finance·Oct 6, 2025
- Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast CancerYahoo Finance·Sep 24, 2025
- Burning Rock Reports Second Quarter 2025 Financial ResultsYahoo Finance·Sep 8, 2025
- 3 Promising Penny Stocks With Market Caps Over $40MYahoo Finance·Jul 16, 2025
- Burning Rock Reports First Quarter 2025 Financial ResultsYahoo Finance·Jun 6, 2025
All 13 articles loaded
Price Data
Open$16.16
Previous Close$17.03
Day High$17.23
Day Low$16.16
52 Week High$41.72
52 Week Low$2.26
52-Week Range
$2.26$41.72
$17.01
Fundamentals
Market Cap$179M
P/E Ratio—
EPS$-0.76
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin-0.1%
Debt / Equity—
Trading
Volume4K
Avg Volume (10D)—
Shares Outstanding8.8M
About Burning Rock Biotech Ltd
Burning Rock Biotech Limited primarily develops and provides screening tests for cancer therapies in the People's Republic of China. The company is headquartered in Guangzhou, China.
HEALTHCAREDIAGNOSTICS & RESEARCH
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDIAGNOSTICS & RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—